|
[1]GOMMA AI, KHAN SA, TOLEDANO MB, et al.Hepatocellularcarcinoma:epidemiology, risk factors and pathogenesis[J].World Gastroenterol, 2008, 14 (27) :4300-4308.
|
|
[2]YANG JD, KIM WR, COELHO R, et al.Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma[J].Clin Gastroenterol Hepatol, 2011, 9 (1) :64-70.
|
|
[3]KEW MC.The role of cirrhosis in the etiology of hepatocellular carcinoma[J].J Gastrointest Cancer, 2014, 45 (1) :12-21.
|
|
[4]LI Y, ZHANG Z, SHI J, et al.Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with HBVassociated liver cirrhosis in China[J].Int J Clin Exp Med, 2015, 8 (1) :1205-1212.
|
|
[5]DI TL, SANGIOVANNI A, BORZIO M, et al.Advanced precancerous lesions in the liver[J].Best Pract Res Clin Gastroenterol, 2013, 27 (2) :269-284.
|
|
[6]HE LL, ZHAO YL, DU LL, et al.Reserch advances in pathological and imaging manifestations of hepatic nodular lesions[J].J Clin Hepatol, 2015, 31 (9) :1547-1550. (in Chinese) 何玲玲, 赵亚林, 杜林林, 等.肝结节性病变的病理和影像学表现[J].临床肝胆病杂志, 2015, 31 (9) :1547-1550.
|
|
[7]Chinese Society of Liver Cancer, Chinese Anti-Cancer Association;Liver Cancer Study Group, Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Pathology, Chinese Anti-Cancer Association, et al.Evidence-based practice guidelines for the standardized pathological diagnosis of primary liver cancer in China (2015 update) [J].J Clin Hepatol, 2015, 31 (6) :833-839. (in Chinese) 中国抗癌协会肝癌专业委员会, 中华医学会肝病会分会肝癌学组, 中国抗癌协会病理专业委员会, 等.原发性肝癌规范化病理诊断指南 (2015年版) [J].临床肝胆病杂志, 2015, 31 (6) :833-839.
|
|
[8]WANLESS IR.Terminology of nodular hepatocellular lesions[J].Hepatology, 1995, 22 (3) :983-993.
|
|
[9]The International Consensus Group for Hepatocellular Neoplasia.Pathologic diagnosis of early hepatocellular carcinoma:a report of the international consensus group for hepatocellular neoplasia[J].Hepatology, 2009, 49 (2) :658-664.
|
|
[10]PARK YN.Update on precursor and early lesions of hepatocellular carcinomas[J].Arch Pathol Lab Med, 2011, 135 (6) :704-715.
|
|
[11]NIU ZS, NIU XJ, WANG WH, et al.Latest developments in precancerous lesions of hepatocellular carcinoma[J].World J Gastroenterol, 2016, 22 (12) :3305-3314.
|
|
[12]SCHLAGETER M, TERRACCIANO LM, D'ANGELO S, et al.Histopathology of hepatocellular carcinoma[M]//Multidisciplinary treatment of hepatocellular carcinoma.Springer, 2013:7-10.
|
|
[13]WONG CM, YAM JW, NG IO.Molecular Pathogenesis of Hepatocellular Carcinoma[M]//Molecular Genetics of Liver Neoplasia.New York:Springer, 2010:160-174.
|
|
[14]KOBAYASHI M, IKEDA K, HOSAKA T, et al.Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis[J].Cancer, 2006, 106 (3) :636-647.
|
|
[15]IAVARONE M, MANINI MA, SANGIOVANNI A, et al.Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis[J].Dig Liver Dis, 2013, 45 (1) :43-49.
|
|
[16]OH BK, KIM YJ, PARK YN, et al.Quantitative assessment of h TERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis[J].Am J Gastroenterol, 2006, 101 (4) :831-838.
|
|
[17]NG CH, CHAN SW, LEE WK, et al.Hepatocarcinogenesis of regenerative and dysplastic nodules in Chinese patients[J].Hong Kong Med J, 2011, 17 (1) :11-19.
|
|
[18]KIM TK, JANG HJ.Contrast-enhanced ultrasound in the diagnosis of nodules in liver cirrhosis[J].World J Gastroenterol, 2014, 20 (13) :3590-3596.
|
|
[19]REN S, YE ZX, ZHU LM.Pathological and imaging features of multistep process of cirrhosis nodules[J].J Clin Hepatol, 2011, 27 (4) :425-428. (in Chinese) 任崧, 叶兆祥, 朱理珉.肝硬化结节多步癌变的病理及影像学表现[J].临床肝胆病杂志, 2011, 27 (4) :425-428.
|
|
[20]WU B, SONG B.Nodular lesions of cirrhotic liver:imaging manifestations with pathologic correlation[J].Chin J Bases Clin Gen Surg, 2003, 10 (3) :288-294. (in Chinese) 吴苾, 宋彬.肝硬变结节性病变的影像学和相关病理学表现[J].中国普外基础与临床杂志, 2003, 10 (3) :288-294.
|
|
[21]SCHRAML C, KAUFMANN S, REMPP H, et al.Imaging of HCC-Current State of the Art[J].Diagnostics, 2015, 5 (4) :513-545.
|
|
[22]JIANG JY, LI XS, MA KS.Application of hepatobiliary-specific MRI contrast agent Gd-EOB-DTPA in preoperative evaluation of hepatobiliary patients[J].J Clin Hepatol, 2015, 31 (6) :996-998. (in Chinese) 蒋家云, 李雪松, 马宽生.钆塞酸二钠在肝胆手术术前评估中的应用[J].临床肝胆病杂志, 2015, 31 (6) :996-998.
|
|
[23]PATEL D, KELL A, SIMARD B, et al.The cell labeling efficacy, cytotoxicity and relaxivity of copper-activated MRI/PET imaging contrast agents[J].Biomaterials, 2011, 32 (4) :1167-1176.
|
|
[24]YOON KT, KIM JK, Ki IMDY, et al.Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma[J].Oncology, 2007, 72 (Suppl 1) :104-110.
|
|
[25]KUHN FP, CROOK DW, MADER CE, et al.Discrimination and anatomical mapping of PET-positive lesions:comparison of CT attenuation-corrected PET images with coregistered MR and CT images in the abdomen[J].Eur J Nucl Med Mol Imaging, 2013, 40 (1) :44-51.
|
|
[26]GONG L, WEI LX, REN P, et al.Dysplastic nodules with glypican-3 positive immunostaining:a risk for early hepatocellular carcinoma[J].PLo S One, 2014, 9 (1) :e87120.
|
|
[27]FU SJ, QI CY, XIAO WK, et al.Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection[J].Surgery, 2013, 154 (3) :536-544.
|
|
[28]DI TL, FRANCHI G, PARK YN, et al.Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis[J].Hepatology, 2007, 45 (3) :725-734.
|
|
[29]DU JL, WEI LX, WANG YL.Expression and clinicopathologic significance of GPC3 and other antibodies in well-differentiated hepatocellular carcinoma[J].Chin J Pathol, 2011, 40 (1) :11-16. (in Chinese) 杜经丽, 韦立新, 王玉兰.磷脂酰肌醇蛋白聚糖3等抗体在高分化肝细胞肝癌中的表达及其鉴别诊断意义[J].中华病理学杂志, 2011, 40 (1) :11-16.
|
|
[30]KONDO F.Histological features of early hepatocellular carcinomas and their developmental process:for daily practical clinical application[J].Hepatol Int, 2009, 3 (1) :283-293.
|
|
[31]PARK YN, KOJIRO M, DI TL, et al.Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules[J].Cancer, 2007, 109 (5) :915-923.
|
|
[32]JEGO G, HAZOUME A, SEIGNEURIC R, et al.Targeting heat shock proteins in cancer[J].Cancer Lett, 2010, 332 (2) :275-285.
|
|
[33]LI RK.Expressions of HSP90α, HSP70, HSP60 incolon cancer tissue and the relationship between the expressions of HSP90α, HSP70, HSP60 and the extent of tissue differentiation[J].J Clin Exp Med, 2015, 14 (9) :721-723. (in Chinese) 李如凯.结肠癌组织中的HSP90α、HSP70、HSP60表达及其与组织分化程度的关系[J].临床和实验医学杂志, 2015, 14 (9) :721-723.
|
|
[34]CHUMA M, SAKAMOTO M, YAMAZAKI K, et al.Expression profiling in multistage hepatocarcinogenesis:identification of HSP70as a molecular marker of early hepatocellular carcinoma[J].Hepatology, 2003, 37 (1) :198-207.
|
|
[35]KOEHNE de GONZALEZ AK, SALOMAO MA, LAGANA SM.Current concepts in the immunohistochemical evaluation of liver tumors[J].World J Hepatol, 2015, 7 (10) :1403-1411.
|
|
[36]LI L, WANG LN, HE BW, et al.Expression of CD34 in hepatocellular carcinoma and analysis of sinusoids[J].Shaanxi Med J, 2007, 36 (5) :577-579. (in Chinese) 李莉, 王莉娜, 贺伯伟, 等.CD34在肝癌发生过程中的表达及肝窦毛细血管化分析[J].陕西医学杂志, 2007, 36 (5) :577-579.
|
|
[37]YAO S, ZHANG J, CHEN H, et al.Diagnostic value of immunohistochemical staining of GP73, GPC3, DCP, CD34, CD31, and reticulin staining in hepatocellular carcinoma[J].J Histochem Cytochem, 2013, 61 (9) :639-648.
|
|
[38]PARKY N, CHAE KJ, KIM YB, et al.Apoptosis and proliferation in hepatocarcinogenesis related to cirrhosis[J].Cancer, 2001, 92 (11) :2733-2738.
|
|
[39]NIU ZS, NIU XJ, WANG M.Management of hepatocellular carcinoma:Predictive value of immunohistochemical markers for postoperative survival[J].World J Hepatol, 2015, 7 (1) :7-27.
|
DownLoad: